Cargando…
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
BACKGROUND: MYC family members are among the most frequently deregulated oncogenes in human cancers, yet direct therapeutic targeting of MYC in cancer has been challenging thus far. Synthetic lethality provides an opportunity for therapeutic intervention of MYC-driven cancers. METHODS: A pooled kina...
Autores principales: | Zhou, Zongxiang, Patel, Manishha, Ng, Nicholas, Hsieh, Mindy H, Orth, Anthony P, Walker, John R, Batalov, Serge, Harris, Jennifer L, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320452/ https://www.ncbi.nlm.nih.gov/pubmed/25495526 http://dx.doi.org/10.1186/1471-2407-14-944 |
Ejemplares similares
-
Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012) -
The Power Decoder Simulator for the Evaluation of Pooled shRNA Screen Performance
por: Stombaugh, Jesse, et al.
Publicado: (2015) -
Generation of a pooled shRNA library for functional genomics screens
por: Papadopoulos, Dimitrios, et al.
Publicado: (2022) -
Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design
por: Martin, Janine N, et al.
Publicado: (2011) -
Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
por: Terasawa, Kazuya, et al.
Publicado: (2011)